Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Standard BioTools (NASDAQ:LAB) through any online brokerage.
Other companies in Standard BioTools’s space includes: 10x Genomics Inc (NASDAQ:TXG), BioLife Solutions Inc (NASDAQ:BLFS), Lifecore Biomedical Inc (NASDAQ:LFCR), Sotera Health Co (NASDAQ:SHC) and Quanterix Corp (NASDAQ:QTRX).
Standard BioTools has a consensus price target of $2.37.
The stock price for Standard BioTools (NASDAQ: LAB) is $1.52 last updated December 17, 2025 at 7:22 PM EST.
There are no upcoming dividends for Standard BioTools.
Standard BioTools does not have any upcoming earnings scheduled.
There is no upcoming split for Standard BioTools.
Standard BioTools is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.